Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Diagnostics Summit 2016

Diagnostics Summit 2016



Guest of Honour

Lim Chuan Poh

Lim Chuan Poh
Chairman, A*STAR

Plenary Speakers

Chwee Teck Lim

Chwee Teck Lim
Provost's Chair Professor, Principal Investigator, Mechanobiology Institute, National University of Singapore

Fred Kramer

Fred Kramer
Professor, New Jersey Medical School Rutgers University

Steven  Myint

Steven Myint
Senior fellow, Consultant, Adjunct Professor, Chairman, ETPL, Duke-NUS, Inex Private Ltd

Jean-Luc  Butel

Jean-Luc Butel
Global Healthcare Advisor, President, K8 Global & Senior Advisor , McKinsey&Company

Rudi Pauwels

Rudi Pauwels
Founder Director/Chief Executive Officer, Biocartis

Overview

Select Bio and the Diagnostics Development Hub, part of Exploit Technologies Pte. Ltd. present Singapore’s Diagnostics Summit 2016

The event will take place on the 13-14 October at the Biopolis, Singapore’s custom built biomedical research and development hub, home to a large number of the world’s leading Life Science organisations and A*STAR research institutes. 

Online Registration closes at 23.59 on Tuesday 11th October. ALL On-Site Registrations will be charged at S$500 cash payments only, no exceptions. On-Site Registrations are not eligible for the 3 for 2 Offer.

Dx Summit is a global diagnostics conference series bringing together global key opinion leaders in diagnostics to generate discussions and develop collaborations which will help to address the unmet clinical needs in this rapidly expanding field. Its focus will be on crucial challenges faced when spearheading market entry into Asia.

We are extremely pleased to introduce our Guest of Honour Mr. Lim Chuan Poh, Chairman of the Agency for Science, Technology and Research, A*STAR, who will be opening the inaugural event.

Our highly distinguished Organising Committee is comprised of; Dr. Sidney Yee, CEO DxD Hub and Executive VP, Incubation & Startup Management Division, Professor Huck Hui Ng, Executive Director GIS, Professor Steven Myint, Senior fellow to A*STAR - ETPL, Adjunct Professor Duke-NUS, Professor Chwee Teck Lim, Department of Biomedical Engineering & Department of Mechanical Engineering, NUS and Xuemei Zhao, Principal Scientist, Molecular Biomarkers and Diagnostics Laboratory, Merck.

There will be two conference tracks, covering the areas of 

Track 1  
  • Circulating DNA, Circulating RNA, Circulating Tumor Cells, Circulating Proteins 
  • Exosomes and Microvesicles 
Track 2  
  • Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development 
  • Technology & Company Showcase, Commercialisation & the Regulatory Landscape 


In addition to the comprehensive conference programme, we will also be holding a Pre-Event Training Course on Wednesday 12th October entitled “Medical Device Regulatory Updates For Major Markets & Clinical Trials For IVD”.

We are also incorporating the 9th Distinguished Technopreneur Speaker Forum into the event- The DTS Series was launched in 2008 as part of A*STAR’s initiatives to seed innovation and entrepreneurship in Singapore. The DTS Forum aims to engage the local research and enterprise community – including entrepreneurs, industry professionals, researchers, scholars or students – and inspire them to explore the potential of enterprise based on innovative technologies. Click here for past news on DTS.

This synergistic forum will catalyse opportunities for entrepreneurs and researchers to translate IPs and into clinically validated diagnostic devices that are ready for market adoption.

With 40 international speakers, this comprehensive event will provide a detailed overview of; the current research, the latest innovations, the regulatory requirements, commercialisation of diagnostic innovations and market entry into Asia. Offering key networking opportunities with the leading international researchers, regulators, innovators and solution providers, this is an important event for all Diagnostics professionals.





Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks